VRPX (VRPX) Stock Price & Analysis
VRPX (VRPX) rose 0.00% to USD 0 as of June 10, 2026 at 03:08 UTC, according to Nexqual real-time market data.
VRPX last closed at USD 0; the session ranged USD 0.02–0.02 on volume of 51 shares. Market capitalization is $497, with a 52-week range of USD 0–0.48 (PNK). Source: Nexqual, June 10, 2026 at 03:08 UTC.
Key Statistics (as of June 10, 2026 at 03:08 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0.02 |
| Day Range | USD 0.02 – 0.02 |
| 52-Week Range | USD 0 – 0.48 |
| Volume | 51 shares |
| Market Cap | $497 |
| Exchange | PNK |
Technical Analysis (VRPX)
Nexqual's technical model rates VRPX "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 03:08 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 32.96 (neutral) |
| vs SMA50 | Below (USD 0) |
| MACD | -0 (negative) |
Analyst Ratings (VRPX)
Wall Street analysts rate VRPX "None", per Nexqual as of June 10, 2026 at 03:08 UTC.
| Consensus Rating | None |
|---|
Earnings (VRPX)
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2024-12-31 | USD 12.5 vs est -6.75 ▲ beat |
| 2024-09-30 | USD -10.75 vs est -13.5 ▲ beat |
| 2024-06-30 | USD -43.75 vs est -38.25 ▼ miss |
Source: Nexqual, June 10, 2026 at 03:08 UTC.
Financials & Fundamentals (VRPX)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| ROE | -2364.82% |
| Current Ratio | 0.63 |
| Total Cash | $1.51M |
| Total Debt | $0 |
| Free Cash Flow | $-12.26M |
Source: Nexqual, June 10, 2026 at 03:08 UTC.
Financial Health Score (VRPX)
Nexqual rates VRPX's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 03:08 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Mixed — $2M cash, no debt |
| Cash Flow | Weak — Operating cash flow -$17M |
| Efficiency | Critical — ROE -2365%, ROA -135.0% |
Ownership (VRPX)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 1.24M |
| Float | 1.05M |
| Short % of Float | +1.81% |
Source: Nexqual, June 10, 2026 at 03:08 UTC.
Leadership (VRPX)
VRPX is led by Jatinder Dhaliwal (age 36), Interim CFO, CEO & Director, per Nexqual as of June 10, 2026 at 03:08 UTC.
| Interim CFO, CEO & Director | Jatinder Dhaliwal (age 36) |
|---|---|
| Chief Scientific Officer | Sheila A. Mathias J.D. (age 57) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MDIA | Mediaco Holding Inc. | USD 0.74 | ▲ 0.96% |
| ENSC | Ensysce Biosciences, Inc. | USD 0.25 | ▲ 0% |
| NRXP | NRX Pharmaceuticals, Inc. | USD 3.87 | ▼ 6.52% |
| INDP | Indaptus Therapeutics, Inc. | USD 2.03 | ▼ 44.67% |
| PTPI | Petros Pharmaceuticals, Inc. | USD 0.01 | ▲ 8.33% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 03:08 UTC. This page is informational and not investment advice.